CannTrust Holdings Inc.

CTST-Q

Analysis and Opinions about CTST-Q

Signal
Opinion
Expert
DON'T BUY
DON'T BUY
July 22, 2019
You find one cockroach, you find others, so there may be more problems involved. Their problems are a warning to the cannabis industry to be more diligent. If any cannabis company's overgrowth winds up on the black market, Health Canada will revoke their license. (He's not saying this is the case with Canntrust.) Selling to medical patients, like Canntrust does, is lucrative.
Show full opinionHide full opinion
You find one cockroach, you find others, so there may be more problems involved. Their problems are a warning to the cannabis industry to be more diligent. If any cannabis company's overgrowth winds up on the black market, Health Canada will revoke their license. (He's not saying this is the case with Canntrust.) Selling to medical patients, like Canntrust does, is lucrative.
COMMENT
COMMENT
July 12, 2019

(opening comment) They raised an amount of cash at their initial offering, so look at the amount of cash per share. Maybe step in near its cash value. You'd be paying nothing for the business. But he doesn't know the specific values and he is only marginally invested in cannabis. There's a risk CTST will lose all its medical customers, so maybe stick closely to the cash value. He owns MediPharm Labs Corp. in this space.

Show full opinionHide full opinion

(opening comment) They raised an amount of cash at their initial offering, so look at the amount of cash per share. Maybe step in near its cash value. You'd be paying nothing for the business. But he doesn't know the specific values and he is only marginally invested in cannabis. There's a risk CTST will lose all its medical customers, so maybe stick closely to the cash value. He owns MediPharm Labs Corp. in this space.

Showing 1 to 2 of 2 entries
  • «
  • 1
  • »